Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Using certain hair products may increase breast cancer risk in black women.

Mouse genital development depends on male or female hormones for specific features.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

New treatments for male hypogonadism are effective and should be personalized.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Decanoic acid may help treat PCOS by reducing androgen levels and improving glucose sensitivity.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Androgens can both increase and decrease hair growth in different parts of the body.